AS
Amos B. Smith

Elite Scholar

1,135
Works
40,338
Citations
95
H-Index
Search Authors
Author Statistics
External Links
OpenAlex Profile ORCID Profile

Amos B. Smith

Also known as: A B Smith, A B Smith III, A B Smith III,, A. B. III SMITH, A. B. III. SMITH

1,135

Total Works

40,338

Citations

95

H-Index

662

i10-Index

Citation & Works Trend by Year
60 years active
Top Research Topics
Organic Chemistry Synthesis Methods (432) Advanced Synthetic Organic Chemistry (318) Asymmetric Synthesis and Catalysis (142) Chemical Synthesis and Analysis (117) Biological Activity of Diterpenoids and Biflavonoids (114)
Recent Publications
15 shown
Year Publication Title Citations Action
2026 A 2nd-generation scalable synthesis of the HIV-1 entry inhibitor CJF-III-288 enabled by photoredox catalysis Chemical Communications 0
2025 The asymmetric opening of HIV-1 Env by a potent CD4 mimetic enables anti-coreceptor binding site antibodies to mediate ADCC Nature Communications 9
2025 Stoichiometry of HIV-1 envelope glycoprotein protomers with changes that stabilize or destabilize the pretriggered conformation mBio 4
2025 Optimization of VE607 to generate analogs with improved neutralization activities against SARS-CoV-2 variants Journal of Virology 0
2025 CD4-mimetics sensitize HIV-infected cells to ADCC mediated by plasma from persons with early-stage HIV-1 infection Journal of Virology 4
2025 Soluble CD4 inhibits Ebola virus infection by targeting endosomal receptor-binding site iScience 0
2025 Safety, pharmacokinetics, and biological activity of CD4-mimetic BNM-III-170 in SHIV-infected rhesus macaques Journal of Virology 3
2025 A gp41 HR2 residue modulates the susceptibility of HIV-1 envelope glycoproteins to small molecule inhibitors targeting gp120 Journal of Virology 6
2025 Conformational activation and disulfide exchange in HIV-1 Env induce cell-free lytic/fusogenic transformation and enhance infection Journal of Virology 2
2024 Optimization of a Piperidine CD4-Mimetic Scaffold Sensitizing HIV-1 Infected Cells to Antibody-Dependent Cellular Cytotoxicity ACS Medicinal Chemistry Letters 2
2024 The combination of three CD4-induced antibodies targeting highly conserved Env regions with a small CD4-mimetic achieves potent ADCC activity Journal of Virology 11
2024 Three families of CD4-induced antibodies are associated with the capacity of plasma from people living with HIV to mediate ADCC in the presence of CD4-mimetics Journal of Virology 13
2024 NTB-A and 2B4 Natural Killer Cell Receptors Modulate the Capacity of a Cocktail of Non-Neutralizing Antibodies and a Small CD4-Mimetic to Eliminate HIV-1-Infected Cells by Antibody-Dependent Cellular Cytotoxicity Viruses 1
2024 Membrane HIV-1 envelope glycoproteins stabilized more strongly in a pretriggered conformation than natural virus Envs iScience 6
2024 HOW ARE RAPID RESPONSE SERVICES IMPLEMENTED OR CHANGED, AND HOW IS THEIR SUCCESS MEASURED? medRxiv 0

Data source: OpenAlex API